Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: A patient survey
R Moraliyska, T Georgiev… - Rheumatology …, 2024 - Springer
To determine the scope of recommended vaccination uptake among patients with
inflammatory arthritis (IA) receiving biologic and targeted synthetic disease-modifying …
inflammatory arthritis (IA) receiving biologic and targeted synthetic disease-modifying …
The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study
A Gastelum-Strozzi, DE Flores-Alvarado… - Rheumatology …, 2023 - Springer
The attitudes toward emerging COVID-19 vaccines have been of great interest worldwide,
especially among vulnerable populations such as patients with rheumatic and …
especially among vulnerable populations such as patients with rheumatic and …
[HTML][HTML] Safety and reported adverse effects of coronavirus disease-2019 (COVID-19) vaccines in patients with rheumatic diseases
FM Aboud, RS Hussein, RM Hassan - The Egyptian Rheumatologist, 2023 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms and severity of COVID19 are …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms and severity of COVID19 are …
Vaccination Rates and Influencing Factors in Patients with Axial Spondyloarthritis and Immunosuppressive Treatment—A Survey-Based Cross-Sectional Study
Patients with axial spondyloarthritis (axSpA) who receive immunosuppressive therapy are at
risk of infection due to impaired immune function and immunosuppressive medication …
risk of infection due to impaired immune function and immunosuppressive medication …
[HTML][HTML] Clinical features, radiological characteristics, and outcome of coronavirus disease-2019 (COVID-19) infection among hospitalized patients with autoimmune …
Background A general comprehension of coronavirus disease-2019 (COVID-19)
characteristics in patients with autoimmune and/or rheumatic diseases (ARDs) is required …
characteristics in patients with autoimmune and/or rheumatic diseases (ARDs) is required …
[PDF][PDF] The Egyptian Rheumatologist
abstract Background: Macrophage activation syndrome (MAS) is characterized by activation
of hemophagocytic cells and is a very rare initial manifestation of systemic lupus …
of hemophagocytic cells and is a very rare initial manifestation of systemic lupus …